Verastem reported $17.71M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
AstraZeneca AZN:LN USD 9.74B 495M
Curis CRIS:US USD 15.43M 2.02M
Cytokinetics CYTK:US USD 133.2M 33.36M
Gilead Sciences GILD:US USD 4.2B 26M
Immunogen IMGN:US USD 92.8M 17.59M
Laboratory Of America LH:US USD 3.14B 34.3M
Novartis NOVN:VX USD 10.67B 183M
Pfizer PFE:US USD 19.12B 5.9B
Roche Holding ROG:VX 20.75B 3.26B
Tg Therapeutics TGTX:US USD 35.06M 4.48M
Verastem VSTM:US USD 17.71M 3.69M
YTE INCY:US USD 684.93M 27.96M
Ziopharm Oncology ZIOP:US USD 11.18M 1.94M